Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Chemicals Specialty Chemicals
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Profit projections
View:
Post by fossi_2002 on Nov 18, 2020 8:04am

Profit projections

I would be happy if Ceapro showed a profit of around 700,000, the chance of an annual profit of around 5c p.sh. would still be realistic.
But the prospects for our projects are certainly more important.
Comment by prophetoffacts on Nov 18, 2020 8:26am
This post has been removed in accordance with Community Policy
Comment by Ciao on Nov 18, 2020 10:20am
Anything above $3M in rev and $600K net would be great.  Reduced R&D from recruiting subjects for the BG pill will help the bottom line as it did in previous quarters. The past 3 financial reports were released on Thursdays, so report could be out tomorrow.  Some selling pressure in the past few days, but with CZO so tight lipped, is it anxious shareholders losing patience on a PGX ...more  
Ceapro Inc